Paclitaxel Eluting Balloon
Highly lipophilic drug ensuring anti-proliferative action.
Efficacy and safety proven as a useful anti-proliferative treatment in coronary arteries.
2.5µg/mm² dosage fully bioavailable on the surface of the balloon.
Paclitaxel polymer free technology combined with a structural forming agent ensures an optimal drug transfer after a 30-second balloon inflation time.
Homogeneous coating applied all around the contact surface.
Consistent coating ensuring delivery of at least 75% of the drug at the lesion site.
Treatment of choice for the side branch after the Nile Pax treatment of the main branch.
Same molecule, same dosage, different technology and still polymer free.